You will now be redirected to the GD3 website
Integrated Analytical Solutions, Inc. is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3SERVICES
Release and Stability Testing of Non-commercial Products
Uncompromising Standards
Are you looking for cost leadership in your discovery-research bioanalysis? Our time-tested approaches to bioanalytical method development for new chemical entities (NCE’s) allows clients to obtain snapshot pharmacokinetic data quickly and economically. The Research Track approach is appropriate for early PK screening, cassette PK studies and analyzing plasma samples from pharmacology efforts.We offer GMP-compliant services to support release and stability of clinical API and drug product. Our systems are designed to meet the most rigorous standards for quality.
IAS scientists will develop and validate analytical methods that perform based on their intended purpose while our QA staff ensures this work complies with both internal and regulatory requirements. This two-pronged approach ensures the integrity of your data and the fitness of systems used to generate it.
